ONTARGET, TRANSCEND, and PRoFESS: new-onset diabetes, atrial fibrillation, and left ventricular hypertrophy-Reference-Cited by-同舟云学术

ONTARGET, TRANSCEND, and PRoFESS: new-onset diabetes, atrial fibrillation, and left ventricular hypertrophy

Published:2009-06 Issue:Suppl 2 Volume:27 Page:S36-S39
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:

Author:

Kintscher Ulrich

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference15 articles.

1. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators [published errata appear in N Engl J Med 2000; 342:748 and 2000; 342:1376];Yusuf;N Engl J Med,2000

2. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol;Dahlof;Lancet,2002

3. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial;Julius;Lancet,2004

4. Effect of ramipril on the incidence of diabetes;Bosch;N Engl J Med,2006

5. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial;Gerstein;Lancet,2006

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Telmisartan increases hepatic glucose production via protein kinase C ζ-dependent insulin receptor substrate-1 phosphorylation in HepG2 cells and mouse liver;Yeungnam University Journal of Medicine;2019-01-31

2. Valsartan, independently of AT1 receptor or PPARγ, suppresses LPS-induced macrophage activation and improves insulin resistance in cocultured adipocytes;American Journal of Physiology-Endocrinology and Metabolism;2012-02

3. Therapeutic perspectives in hypertension: novel means for renin-angiotensin-aldosterone system modulation and emerging device-based approaches;European Heart Journal;2011-09-27

4. The central mechanism underlying hypertension: a review of the roles of sodium ions, epithelial sodium channels, the renin–angiotensin–aldosterone system, oxidative stress and endogenous digitalis in the brain;Hypertension Research;2011-08-04

5. Drug therapy for the prevention of type 2 diabetes – is there a medical rationale?;The British Journal of Diabetes & Vascular Disease;2011-07